...Impax Laboratories, Inc. engages in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. As of March #, ####, the company had approximately ## generic products approved or pending approval, or under development, which consisted of ## abbreviated new drug applications (ANDAs) approved by the FDA, which include generic versions of brand name pharmaceuticals, such as Brethine, Florinef, Minocin, Claritin -D ## -hour, Claritin -D ## -hour, Wellbutrin SR, and Prilosec; ## applications pending at the FDA, including generic versions of OxyContin, Allegra D, and Tricor; and ## other products in various stages of development, which are for generic versions of brand name pharmaceuticals. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail -order pharmacies through strategic alliances and the company...

Source: LIFE SCIENCE ANALYTICS
Company: IMPAX LABORATORIES INC
Geographic Regions: CALIFORNIA (STATE OF), NORTH AMERICA, PACIFIC STATES REGION, UNITED STATES OF AMERICA

Enter the keyword(s) which you would like to search for within this document and click "Search"

 

 TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.